NO20011412L - Methods for down-modulating the immune response to therapeutic proteins - Google Patents

Methods for down-modulating the immune response to therapeutic proteins

Info

Publication number
NO20011412L
NO20011412L NO20011412A NO20011412A NO20011412L NO 20011412 L NO20011412 L NO 20011412L NO 20011412 A NO20011412 A NO 20011412A NO 20011412 A NO20011412 A NO 20011412A NO 20011412 L NO20011412 L NO 20011412L
Authority
NO
Norway
Prior art keywords
modulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
NO20011412A
Other languages
Norwegian (no)
Other versions
NO20011412D0 (en
Inventor
Jiahua Qian
Leon W Hoyer
Mary Collins
Gary S Gray
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of NO20011412D0 publication Critical patent/NO20011412D0/en
Publication of NO20011412L publication Critical patent/NO20011412L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20011412A 1998-09-21 2001-03-20 Methods for down-modulating the immune response to therapeutic proteins NO20011412L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21
PCT/US1999/021991 WO2000016801A1 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Publications (2)

Publication Number Publication Date
NO20011412D0 NO20011412D0 (en) 2001-03-20
NO20011412L true NO20011412L (en) 2001-05-16

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011412A NO20011412L (en) 1998-09-21 2001-03-20 Methods for down-modulating the immune response to therapeutic proteins

Country Status (21)

Country Link
EP (1) EP1115423A1 (en)
JP (1) JP2002526455A (en)
KR (1) KR20010085830A (en)
CN (1) CN1331602A (en)
AU (1) AU761206B2 (en)
BR (1) BR9913991A (en)
CA (1) CA2343916A1 (en)
CZ (1) CZ20011021A3 (en)
EA (1) EA005236B1 (en)
HK (1) HK1039059A1 (en)
HU (1) HUP0103960A3 (en)
IL (1) IL142069A0 (en)
LT (1) LT4920B (en)
LV (1) LV12768B (en)
MX (1) MXPA01002898A (en)
NO (1) NO20011412L (en)
NZ (1) NZ511034A (en)
PL (1) PL346796A1 (en)
SI (1) SI20626A (en)
WO (1) WO2000016801A1 (en)
ZA (1) ZA200103156B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
DE60118362T2 (en) * 2000-05-19 2007-05-24 The Center for Blood Research, Inc., Boston METHOD FOR TREATING HEMOSTATIC INTERFERENCE BY SOLUBLE P-SELECTIN
US7040139B2 (en) * 2003-06-10 2006-05-09 Smiths Detection Inc. Sensor arrangement
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
US4868112A (en) 1985-04-12 1989-09-19 Genetics Institute, Inc. Novel procoagulant proteins
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (en) 1990-02-05 1994-09-02 Tm Innovation PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
AU661854B2 (en) 1991-06-27 1995-08-10 Bristol-Myers Squibb Company CTL4A receptor, fusion proteins containing it and uses thereof
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
WO1996005860A1 (en) * 1994-08-19 1996-02-29 Novo Nordisk A/S A method of treating a patient with a biologically active compound
WO1996012406A1 (en) * 1994-10-19 1996-05-02 Genetic Therapy, Inc. Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DK0892643T4 (en) * 1996-03-20 2009-12-14 Bristol Myers Squibb Co Methods for inhibiting an immune response by blocking the GP39 / CD40 and CTLA4 / CD28 / B7 pathways and preparations for use therewith
DE69837322T2 (en) * 1997-01-10 2007-11-22 Biogen Idec Ma Inc., Cambridge METHOD FOR THE THERAPEUTIC ADMINISTRATION OF ANTI-CD40L MEDIUM
CN1261285A (en) * 1997-06-20 2000-07-26 拜奥根有限公司 CD 154 blockade therapy for therapeutic protein inhibitor syndrome
US8082673B2 (en) 2009-11-06 2011-12-27 Hexagon Metrology Ab Systems and methods for control and calibration of a CMM

Also Published As

Publication number Publication date
EA200100385A1 (en) 2001-10-22
LV12768A (en) 2001-12-20
HK1039059A1 (en) 2002-04-12
LV12768B (en) 2002-06-20
CN1331602A (en) 2002-01-16
ZA200103156B (en) 2002-07-18
CZ20011021A3 (en) 2001-10-17
EP1115423A1 (en) 2001-07-18
HUP0103960A2 (en) 2002-02-28
AU761206B2 (en) 2003-05-29
LT2001045A (en) 2002-01-25
NO20011412D0 (en) 2001-03-20
AU6057899A (en) 2000-04-10
IL142069A0 (en) 2002-03-10
EA005236B1 (en) 2004-12-30
KR20010085830A (en) 2001-09-07
LT4920B (en) 2002-06-25
PL346796A1 (en) 2002-02-25
SI20626A (en) 2002-02-28
WO2000016801A1 (en) 2000-03-30
BR9913991A (en) 2001-07-03
HUP0103960A3 (en) 2003-09-29
JP2002526455A (en) 2002-08-20
NZ511034A (en) 2004-03-26
WO2000016801A9 (en) 2000-10-26
MXPA01002898A (en) 2002-06-04
CA2343916A1 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
IS5375A (en) KAY-Innovative Immune Protein
NO985464D0 (en) Concentrated antibody preparation
NO20004133L (en) Antibodies to human CD40
NO983766D0 (en) Process for the preparation of N-acetyl-D-glucosamine
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
NO995134L (en) Improved Methods for Preparation of Activated Protein C
ID24314A (en) PLACE TO PLACE FAST-APPROXIMATELY
NO20004523D0 (en) Delivery system to Õ modulate the immune response
NO960482D0 (en) The outsole
NO995251D0 (en) Procedure for administering halotherapy
TR199802394A3 (en) Improved process to stabilize proteins.
DK1109450T3 (en) The microcapsule preparations
TR199501501A2 (en) Preparation of the sugars.
NO975563L (en) Device for holding two objects together
NO20010842L (en) Connecting element for connecting two components
DE69926012D1 (en) PHARMACEUTICAL PREPARATIONS
TR199800403A3 (en) Method for the preparation of a-Bromo-lactam derivatives.
NO20011412D0 (en) Methods for down-modulating the immune response to therapeutic proteins
DE69823490D1 (en) antiperspirant PREPARATION
NO996432D0 (en) Process for the preparation of 4-substituted-1H-indole-3-glycosamides
FI951155A (en) Pharmaceutical preparation
DE69906934D1 (en) PHARMACEUTICAL PREPARATIONS
ID17941A (en) METHOD OF THE APPLICATION OF MARKA JALAN MAKERS COMPOSITION
NO951679L (en) Fibronectin-binding protein, as well as its preparation
NO980316D0 (en) Process for the preparation of N-vinylcarprolactam polymerisates

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application